Above, photo submitted by Keith Klugman, The Bill & Melinda Gates Foundation
- Ting Shi, University of Edinburgh: ”Global disease burden estimate of RSV in young children”
- Louis Bont, University Medical Center Utrecht: ”RSV clinical presentation and disease severity”
- Marijke Proesmans, University Hospital Leuven: ”RSV therapeutics for the future”
- Keith Klugman, Bill & Melinda Gates Foundation: ”RSV immunization and future directions”
Webinar date: March 19, 2019
View the presentation using the SlideShare link.